Pfizer Inc. (BIT:1PFE)

Italy flag Italy · Delayed Price · Currency is EUR
20.74
+0.14 (0.70%)
At close: May 30, 2025, 5:30 PM CET
-21.23%
Market Cap 117.70B
Revenue (ttm) 57.67B
Net Income (ttm) 7.28B
Shares Out n/a
EPS (ttm) 1.28
PE Ratio 16.17
Forward PE 8.24
Dividend 1.57 (7.57%)
Ex-Dividend Date May 8, 2025
Volume 7,719
Average Volume 8,209
Open 20.66
Previous Close 20.59
Day's Range 20.60 - 20.76
52-Week Range 18.73 - 29.30
Beta n/a
RSI 47.33
Earnings Date Jul 29, 2025

About Pfizer

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular and migraine under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral pr... [Read more]

Industry Pharmaceutical Preparations
Founded 1849
Employees 81,000
Stock Exchange Borsa Italiana
Ticker Symbol 1PFE
Full Company Profile

Financial Performance

In 2024, Pfizer's revenue was $63.63 billion, an increase of 6.84% compared to the previous year's $59.55 billion. Earnings were $8.03 billion, an increase of 279.00%.

Financial numbers in USD Financial Statements

News

There is no news available yet.